N

Nykode Therapeutics ASA
OSE:NYKD

Watchlist Manager
Nykode Therapeutics ASA
OSE:NYKD
Watchlist
Price: 2.678 NOK 0.6% Market Closed
Market Cap: 874.5m NOK

Wall Street
Price Targets

NYKD Price Targets Summary
Nykode Therapeutics ASA

Wall Street analysts forecast NYKD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NYKD is 5.44 NOK with a low forecast of 2.525 NOK and a high forecast of 8.925 NOK.

Lowest
Price Target
2.525 NOK
6% Downside
Average
Price Target
5.44 NOK
103% Upside
Highest
Price Target
8.925 NOK
233% Upside
Nykode Therapeutics ASA Competitors:
Price Targets
600201
Jinyu Bio-Technology Co Ltd
14% Upside
1952
Everest Medicines Ltd
19% Upside
EXAS
Exact Sciences Corp
25% Upside
HPHA
Heidelberg Pharma AG
298% Upside
GNFT
Genfit SA
156% Upside
002252
Shanghai RAAS Blood Products Co Ltd
3% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
43% Upside
068270
Celltrion Inc
58% Upside

Revenue
Forecast

Revenue Estimate
Nykode Therapeutics ASA

For the last 7 years the compound annual growth rate for Nykode Therapeutics ASA's revenue is 110%.

110%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Nykode Therapeutics ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Nykode Therapeutics ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NYKD's stock price target?
Price Target
5.44 NOK

According to Wall Street analysts, the average 1-year price target for NYKD is 5.44 NOK with a low forecast of 2.525 NOK and a high forecast of 8.925 NOK.

Back to Top